Mayo Clinic Zentalis Pharmaceuticals, Inc. Transaction History
Mayo Clinic
- $2.86 Million
- Q2 2024
A detailed history of Mayo Clinic transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mayo Clinic holds 187,143 shares of ZNTL stock, worth $553,943. This represents 26.74% of its overall portfolio holdings.
Number of Shares
187,143
Previous 187,143
-0.0%
Holding current value
$553,943
Previous $2.95 Million
74.06%
% of portfolio
26.74%
Previous 52.87%
Shares
6 transactions
Others Institutions Holding ZNTL
# of Institutions
148Shares Held
69.8MCall Options Held
61.8KPut Options Held
6.6K-
Matrix Capital Management Company, LP Waltham, MA14MShares$41.3 Million0.43% of portfolio
-
Eventide Asset Management, LLC Boston, MA8.55MShares$25.3 Million0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$16.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$14.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.5MShares$13.3 Million0.0% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $169M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...